Review: Frontiers of Antifibrotic Therapy in Systemic Sclerosis
Arthritis Rheumatol
.
2017 Feb;69(2):257-267.
doi: 10.1002/art.39865.
Authors
Jörg H W Distler
1
,
Carol Feghali-Bostwick
2
,
Alina Soare
1
,
Yoshihide Asano
3
,
Oliver Distler
4
,
David J Abraham
5
Affiliations
1
University of Erlangen-Nuremberg, Erlangen, Germany.
2
Medical University of South Carolina, Charleston.
3
University of Tokyo Graduate School of Medicine, Tokyo, Japan.
4
University Hospital Zurich, Zurich, Switzerland.
5
University College London Medical School, London, UK.
PMID:
27636741
DOI:
10.1002/art.39865
No abstract available
Publication types
Research Support, Non-U.S. Gov't
Review
MeSH terms
Drug Discovery*
Fibrosis
Humans
Scleroderma, Systemic / drug therapy*
Scleroderma, Systemic / etiology
Scleroderma, Systemic / pathology
Grants and funding
18420/ARC_/Arthritis Research UK/United Kingdom
18420/VAC_/Versus Arthritis/United Kingdom
19427/ARC_/Arthritis Research UK/United Kingdom
19427/VAC_/Versus Arthritis/United Kingdom